Thomas Dicker

SymbioFCell SA manufactures and industrializes hydrogen fuel systems. It also engages in the development, assembly and integration of its fuel systems. The firm’s product applications include industrial and automotive embarkation, such as short- and mid-range trucks, industrial and specialized vehicles, buses, trams, ferries and barges. The company was founded by Fabio Ferrari in 2010 and is headquartered in Grenoble, France.

AGC Biologics A/S provides contract process development and biopharmaceuticals manufacturing services worldwide. It specializes in delivering custom solutions for the scale-up and the cGMP manufacture of protein-based therapeutics for pre-clinical, clinical trials, and commercial production. Its services include cell line development, bioprocess development, formulation, and analytical testing. The company was founded by Peter Vilby, Mads Laustsen, Thomas Sandal, and Morten Munk in 2001 and is headquartered in Soeborg, Denmark.

BW Ideol specializes in the designing and installation of foundation solutions for the offshore wind industry. It offers ring-shaped platforms for offshore wind turbines and engineering and installation services. The company was founded by Pierre Coulombeau and Paul de la Guérivière in June 2010 and is headquartered in La Ciotat, France.

I-TEN SA manufactures and markets micro batteries. It serves data backup, smart cards, autonomous sensors, medical and specialty applications. The company was founded by Fabien Gaben in 2011 and is headquartered in Champagne-au-Mont-d'Or, France.

Demeter Partners SA (Demeter Partners) is a French private equity firm which was founded in 2005 by Sophie Paturle-Guesnerot and Stéphane Villecroze and is majority-owned by the management team. Headquartered in Paris with an additional office in Madrid, Demeter Partners has partnerships with English, German and Spanish funds which are involved in their sectors and are also members of international networks of investors specialized in 'clean technologies'. The firm manages the Demeter Fund, sponsored by the Caisse des Dépôts (CDC Entreprises) and the Institut Français du Pétrole (French Petroleum Institute) for institutional investors including life insurance companies, health insurance companies, pension funds and sophisticated private investors.

CEA Investissement SA (CEA-I), formerly known as CEA Valorisation, is the corporate venture arm and a wholly-owned subsidiary of CEA-Commissariat à l'Energie Atomique, which is the French governmental agency in charge of civilian and defense nuclear research. CEA-I was established in 1999 and is located in Grenoble, a large city in the southeast of France. CEA-I manages a portfolio of direct participations in high-technology companies. The firm also provides services related to IP protection for research done at CEA, by other public research entities or within private companies.

Innoven Partners is an investment fund. The private company is based in Paris, France.

BioVex Group, Inc. operates as a clinical-stage biotechnology company. It focuses on the development and commercialization of targeted treatments for cancer and the prevention of infectious disease. The company was founded in 1999 and is headquartered in Woburn, MA.

BioVex Ltd. operates as a biotechnology firm. It focuses on the development and commercialization of biological treatments for cancer and the prevention of infectious disease. The company was founded on December 15, 1997 and is headquartered in Cambridge, the United Kingdom.

BioVex, Inc. develops vaccines for the treatment of cancer and the prevention of chronic infectious diseases. Its products include OncoVEX oncolytic and ImmunoVEX technology. The company was founded in 1999 by Dr. Robert Coffin and is headquartered in Woburn, MA.

Cornell University is an educational institution that offers undergraduate and post graduate programs. It was founded in 1865 and is based in Ithaca, NY.

Generis Capital Partners SAS (GCP) is an independent venture capital and private equity firm founded in 2008 by Thibaut de Roux. The firm is headquartered in Paris, France.

Dr. Reddy's Research & Development BV is engaged in the development and manufacture of injectable pharmaceutical products. It provides formulation, development, drug delivery, and clinical material manufacturing services to biotech and pharmaceutical companies worldwide. The company was founded by Joost J. M. Holthuis on July 20, 1995 and is headquartered in Leiden, Netherlands.

Amati Global Investors Ltd. (Venture Capital) is a Venture Capital firm, a subsidiary of Amati Global Investors Ltd. founded in 1999. The firm is headquartered in Edinburgh.

Innovacom Gestion SAS (Innovacom) is a venture capital firm founded in 1988 and a subsidiary of Turenne Capital Partenaires. Innovacom is headquartered in Paris, France with additional offices in Stockholm and San Francisco.